Skip to main content
Erschienen in: Lung 1/2019

25.10.2018 | RESPIRATORY PHYSIOLOGY

Cough Effectiveness and Pulmonary Hygiene Practices in Patients with Pompe Disease

verfasst von: Teresa Pitts, Rachel Bordelon, Alyssa Huff, Barry J. Byrne, Barbara K. Smith

Erschienen in: Lung | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

While factors leading to hypoventilation have been well studied in Pompe disease, cough effectiveness and airway clearance practices are less understood. We aimed to identify significant factors that influence peak cough flow (PCF) in Pompe, and to detect whether pulmonary hygiene practices were reflective of reduced PCF.

Methods

This is a prospective observational study of 20 subjects with Pompe disease (infantile-onset: 7, juvenile-onset: 6, adult-onset: 14). Subjects performed spirometry, maximal respiratory pressures, and cough (voluntary: n = 24, spontaneous: n = 3). Subjects or their parents reported airway clearance and secretion management practices. Relationships between disease variables, pulmonary function, and cough parameters as well as group differences in cough parameters were evaluated.

Results

Subjects with infantile-onset disease had significantly lower PCF (p < 0.05) and tended to require more external ventilatory support (p = 0.07). In juvenile- and adult-onset disease, PCF differed according to external ventilatory requirement [daytime: 83.6 L/min (95% CI 41.2–126.0); nighttime: 224.6 L/min (95% CI 139.1–310.2); none: 340.2 L/min (95% CI 193.3–487.6), p < 0.005]. Cough inspiratory volume also differed significantly by ventilatory requirement [daytime: 5.5 mL/kg (95% CI 3.0–8.0); nighttime: 16.0 mL/kg (95% CI 11.8–20.2); none: 26.8 mL/kg (95% CI 11.9–41.7), p < 0.001]. However, routine airway clearance or secretion management practices were only consistently reported among patients with infantile-onset disease (infantile: 86%, juvenile: 0%, adult: 14%, p < 0.005).

Conclusions

Cough weakness was detected in the majority of patients with Pompe disease and was influenced by both inspiratory and expiratory muscle function. Patients at risk for problems or with ineffective PCF should be urged to complete routine pulmonary hygiene.
Literatur
2.
Zurück zum Zitat American Association of Neuromuscular & Electrodiagnostic Medicine (2009) Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 40:149–160CrossRef American Association of Neuromuscular & Electrodiagnostic Medicine (2009) Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 40:149–160CrossRef
3.
Zurück zum Zitat Boentert M, Prigent H, Vardi K et al (2016) Practical recommendations for diagnosis and management of respiratory muscle weakness in late-onset Pompe disease. Int J Mol Sci 17 Boentert M, Prigent H, Vardi K et al (2016) Practical recommendations for diagnosis and management of respiratory muscle weakness in late-onset Pompe disease. Int J Mol Sci 17
4.
Zurück zum Zitat Gungor D, de Vries JM, Hop WC et al (2011) Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy. Orphanet J Rare Dis 6:34CrossRefPubMedPubMedCentral Gungor D, de Vries JM, Hop WC et al (2011) Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy. Orphanet J Rare Dis 6:34CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Schoser B, Fong E, Geberhiwot T et al (2017) Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature. Orphanet J Rare Dis 12:52CrossRefPubMedPubMedCentral Schoser B, Fong E, Geberhiwot T et al (2017) Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature. Orphanet J Rare Dis 12:52CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Bach JR, Saporito LR (1996) Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. Chest 110:1566–1571CrossRefPubMed Bach JR, Saporito LR (1996) Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. Chest 110:1566–1571CrossRefPubMed
7.
Zurück zum Zitat Bach JR, Goncalves MR, Hamdani I, Winck JC (2010) Extubation of patients with neuromuscular weakness: a new management paradigm. Chest 137:1033–1039CrossRef Bach JR, Goncalves MR, Hamdani I, Winck JC (2010) Extubation of patients with neuromuscular weakness: a new management paradigm. Chest 137:1033–1039CrossRef
8.
Zurück zum Zitat Bach JR, Ishikawa Y, Kim H (1997) Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 112:1024–1028CrossRefPubMed Bach JR, Ishikawa Y, Kim H (1997) Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 112:1024–1028CrossRefPubMed
9.
Zurück zum Zitat Jones HN, Crisp KD, Robey RR, Case LE, Kravitz RM, Kishnani PS (2015) Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): effects of training and detraining. Mol Genet Metab 117:120–128CrossRefPubMed Jones HN, Crisp KD, Robey RR, Case LE, Kravitz RM, Kishnani PS (2015) Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): effects of training and detraining. Mol Genet Metab 117:120–128CrossRefPubMed
10.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338CrossRef Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338CrossRef
11.
Zurück zum Zitat European, Respiratory Society, American Thoracic Society (2002) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518–624CrossRef European, Respiratory Society, American Thoracic Society (2002) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518–624CrossRef
12.
Zurück zum Zitat Chatwin M, Toussaint M, Goncalves MR et al (2018) Airway clearance techniques in neuromuscular disorders: a state of the art review. Respir Med 136:98–110CrossRef Chatwin M, Toussaint M, Goncalves MR et al (2018) Airway clearance techniques in neuromuscular disorders: a state of the art review. Respir Med 136:98–110CrossRef
13.
Zurück zum Zitat Kroos M, Hoogeveen-Westerveld M, van der Ploeg A, Reuser AJ (2012) The genotype-phenotype correlation in Pompe disease. Am J Med Genet C 160:59–68CrossRef Kroos M, Hoogeveen-Westerveld M, van der Ploeg A, Reuser AJ (2012) The genotype-phenotype correlation in Pompe disease. Am J Med Genet C 160:59–68CrossRef
14.
Zurück zum Zitat Morrow B, Zampoli M, van Aswegen H, Argent A (2013) Mechanical insufflation-exsufflation for people with neuromuscular disorders. Cochrane Database Syst Rev 2013:CD010044 Morrow B, Zampoli M, van Aswegen H, Argent A (2013) Mechanical insufflation-exsufflation for people with neuromuscular disorders. Cochrane Database Syst Rev 2013:CD010044
15.
Zurück zum Zitat Mahede T, Davis G, Rutkay A et al (2015) Use of mechanical airway clearance devices in the home by people with neuromuscular disorders: effects on health service use and lifestyle benefits. Orphanet J Rare Dis 10:54CrossRefPubMedPubMedCentral Mahede T, Davis G, Rutkay A et al (2015) Use of mechanical airway clearance devices in the home by people with neuromuscular disorders: effects on health service use and lifestyle benefits. Orphanet J Rare Dis 10:54CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Arora NS, Gal TJ (1981) Cough dynamics during progressive expiratory muscle weakness in healthy curarized subjects. J Appl Physiol 51:494–498CrossRefPubMed Arora NS, Gal TJ (1981) Cough dynamics during progressive expiratory muscle weakness in healthy curarized subjects. J Appl Physiol 51:494–498CrossRefPubMed
17.
Zurück zum Zitat Prigent H, Orlikowski D, Laforet P et al (2012) Supine volume drop and diaphragmatic function in adults with Pompe disease. Eur Respir J 39:1545–1546CrossRefPubMed Prigent H, Orlikowski D, Laforet P et al (2012) Supine volume drop and diaphragmatic function in adults with Pompe disease. Eur Respir J 39:1545–1546CrossRefPubMed
18.
Zurück zum Zitat Smith BK, Corti M, Martin AD, Fuller DD, Byrne BJ (2016) Altered activation of the diaphragm in late-onset Pompe disease. Respir Physiol Neurobiol 222:11–15CrossRefPubMed Smith BK, Corti M, Martin AD, Fuller DD, Byrne BJ (2016) Altered activation of the diaphragm in late-onset Pompe disease. Respir Physiol Neurobiol 222:11–15CrossRefPubMed
19.
Zurück zum Zitat LoMauro A, D’Angelo MG, Aliverti A (2015) Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options. Ther Clin Risk Manage 11:1475–1488 LoMauro A, D’Angelo MG, Aliverti A (2015) Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options. Ther Clin Risk Manage 11:1475–1488
20.
Zurück zum Zitat Sarmento A, de Andrade AF, Lima IN, Aliverti A, de Freitas Fregonezi GA, Resqueti VR (2017) Air stacking: a detailed look into physiological acute effects on cough peak flow and chest wall volumes of healthy subjects. Respir Care 62:432–443CrossRefPubMed Sarmento A, de Andrade AF, Lima IN, Aliverti A, de Freitas Fregonezi GA, Resqueti VR (2017) Air stacking: a detailed look into physiological acute effects on cough peak flow and chest wall volumes of healthy subjects. Respir Care 62:432–443CrossRefPubMed
21.
Zurück zum Zitat Trebbia G, Lacombe M, Fermanian C et al (2005) Cough determinants in patients with neuromuscular disease. Respir Physiol Neurobiol 146:291–300CrossRefPubMed Trebbia G, Lacombe M, Fermanian C et al (2005) Cough determinants in patients with neuromuscular disease. Respir Physiol Neurobiol 146:291–300CrossRefPubMed
22.
23.
Zurück zum Zitat McCool FD (2006) Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest 129:48S–53SCrossRef McCool FD (2006) Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest 129:48S–53SCrossRef
24.
Zurück zum Zitat Laghi F, Maddipati V, Schnell T, Langbein WE, Tobin MJ (2017) Determinants of cough effectiveness in patients with respiratory muscle weakness. Respir Physiol Neurobiol 240:17–25CrossRefPubMed Laghi F, Maddipati V, Schnell T, Langbein WE, Tobin MJ (2017) Determinants of cough effectiveness in patients with respiratory muscle weakness. Respir Physiol Neurobiol 240:17–25CrossRefPubMed
25.
Zurück zum Zitat McKim DA, Hendin A, LeBlanc C, King J, Brown CR, Woolnough A (2012) Tracheostomy decannulation and cough peak flows in patients with neuromuscular weakness. Am J Phys Med Rehabil 91:666–670CrossRefPubMed McKim DA, Hendin A, LeBlanc C, King J, Brown CR, Woolnough A (2012) Tracheostomy decannulation and cough peak flows in patients with neuromuscular weakness. Am J Phys Med Rehabil 91:666–670CrossRefPubMed
26.
Zurück zum Zitat Gaeta M, Barca E, Ruggeri P et al (2013) Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. Mol Genet Metab 110:290–296CrossRefPubMed Gaeta M, Barca E, Ruggeri P et al (2013) Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function. Mol Genet Metab 110:290–296CrossRefPubMed
27.
Zurück zum Zitat Yasuda T, Wu C, Nakagawa N, Nagamura K (2013) Studies on an automobile muffler with the acoustic characteristic of low-pass filter and Helmholtz resonator. Appl Acoust 74:49–57CrossRef Yasuda T, Wu C, Nakagawa N, Nagamura K (2013) Studies on an automobile muffler with the acoustic characteristic of low-pass filter and Helmholtz resonator. Appl Acoust 74:49–57CrossRef
28.
Zurück zum Zitat Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK (2003) Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J 21:502–508CrossRefPubMed Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK (2003) Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J 21:502–508CrossRefPubMed
29.
Zurück zum Zitat Bianchi C, Baiardi P (2008) Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil 87:461–467CrossRefPubMed Bianchi C, Baiardi P (2008) Cough peak flows: standard values for children and adolescents. Am J Phys Med Rehabil 87:461–467CrossRefPubMed
30.
Zurück zum Zitat Dohna-Schwake C, Ragette R, Teschler H, Voit T, Mellies U (2006) Predictors of severe chest infections in pediatric neuromuscular disorders. Neuromuscul Disord 16:325–328CrossRefPubMed Dohna-Schwake C, Ragette R, Teschler H, Voit T, Mellies U (2006) Predictors of severe chest infections in pediatric neuromuscular disorders. Neuromuscul Disord 16:325–328CrossRefPubMed
31.
Zurück zum Zitat Hull J, Aniapravan R, Chan E et al (2012) British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax 67(Suppl 1):i1–i40CrossRefPubMed Hull J, Aniapravan R, Chan E et al (2012) British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax 67(Suppl 1):i1–i40CrossRefPubMed
32.
Zurück zum Zitat Lee KK, Ward K, Rafferty GF, Moxham J, Birring SS (2015) The intensity of voluntary, induced, and spontaneous cough. Chest 148:1259–1267CrossRefPubMed Lee KK, Ward K, Rafferty GF, Moxham J, Birring SS (2015) The intensity of voluntary, induced, and spontaneous cough. Chest 148:1259–1267CrossRefPubMed
Metadaten
Titel
Cough Effectiveness and Pulmonary Hygiene Practices in Patients with Pompe Disease
verfasst von
Teresa Pitts
Rachel Bordelon
Alyssa Huff
Barry J. Byrne
Barbara K. Smith
Publikationsdatum
25.10.2018
Verlag
Springer US
Erschienen in
Lung / Ausgabe 1/2019
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-018-0171-1

Weitere Artikel der Ausgabe 1/2019

Lung 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.